Functional Outcomes of High-Risk Prostate Cancer Patients Treated With Neoadjuvant Androgen Deprivation Therapy (nADT) Prior to Radical Prostatectomy.
INTRODUCTION The oncological benefit of neoadjuvant androgen deprivation therapy (nADT) in high-risk prostate cancer patients has not been proven. The effect of nADT on long-term functional outcomes, namely urinary continence and potency, after radical prostatectomy (RP) is unknown. PATIENTS AND METHODS This retrospe...